Non-Q-wave myocardial infarction: a prognostic paradox.
It is now clear that non-Q-wave MI, whose incidence appears to be rising, carries an increased risk of reinfarction and recurrent ischemia. Indeed, non-Q-wave late mortality may equal or exceed that of its Q-wave counterpart. The management question: Should the patient with non-Q-wave MI have myocardial revascularization or strictly medical therapy?
Boden
W E
WE
Tufts University School of Medicine, Boston.
D017023:Coronary Angiography; D003937:Diagnosis, Differential; D004110:Diltiazem / Q000627:therapeutic use; D004341:Drug Evaluation; D004562:Electrocardiography; D006333:Heart Failure / Q000175:diagnosis / Q000401:mortality; D006801:Humans; D009203:Myocardial Infarction / Q000145:classification / Q000175:diagnosis* / Q000188:drug therapy / Q000401:mortality; D011379:Prognosis; D011446:Prospective Studies
D004110:Diltiazem